“Impact of Etelcalcetide on Cardiovascular Outcomes and Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism: A Meta-Analysis”, OAIJMR, vol. 5, no. 1, pp. 41–54, Mar. 2025, doi: 10.37275/oaijmr.v5i1.701.